These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32542678)

  • 21. Augmented mixed models for clustered proportion data.
    Bandyopadhyay D; Galvis DM; Lachos VH
    Stat Methods Med Res; 2017 Apr; 26(2):880-897. PubMed ID: 25491718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian variable selection for multivariate zero-inflated models: Application to microbiome count data.
    Lee KH; Coull BA; Moscicki AB; Paster BJ; Starr JR
    Biostatistics; 2020 Jul; 21(3):499-517. PubMed ID: 30590511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian hierarchical modelling of continuous non-negative longitudinal data with a spike at zero: An application to a study of birds visiting gardens in winter.
    Swallow B; Buckland ST; King R; Toms MP
    Biom J; 2016 Mar; 58(2):357-71. PubMed ID: 25737026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian spatiotemporal analysis of zero-inflated biological population density data by a delta-normal spatiotemporal additive model.
    Arcuti S; Pollice A; Ribecco N; D'Onghia G
    Biom J; 2016 Mar; 58(2):372-86. PubMed ID: 26418888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian restoration of ion channel records using hidden Markov models.
    Rosales R; Stark JA; Fitzgerald WJ; Hladky SB
    Biophys J; 2001 Mar; 80(3):1088-103. PubMed ID: 11222275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing Monte Carlo error in the Bayesian estimation of risk ratios using log-binomial regression models.
    Salmerón D; Cano JA; Chirlaque MD
    Stat Med; 2015 Aug; 34(19):2755-67. PubMed ID: 25944082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian inference for two-part mixed-effects model using skew distributions, with application to longitudinal semicontinuous alcohol data.
    Xing D; Huang Y; Chen H; Zhu Y; Dagne GA; Baldwin J
    Stat Methods Med Res; 2017 Aug; 26(4):1838-1853. PubMed ID: 26092477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement error models with zero inflation and multiple sources of zeros, with applications to hard zeros.
    Bhadra A; Wei R; Keogh R; Kipnis V; Midthune D; Buckman DW; Su Y; Chowdhury AR; Carroll RJ
    Lifetime Data Anal; 2024 Jul; 30(3):600-623. PubMed ID: 38806842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals.
    Pillonetto G; Sparacino G; Magni P; Bellazzi R; Cobelli C
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E564-73. PubMed ID: 11832358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hierarchical Bayesian modeling of spatially correlated health service outcome and utilization rates.
    MacNab YC
    Biometrics; 2003 Jun; 59(2):305-16. PubMed ID: 12926715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint oligogenic segregation and linkage analysis using bayesian Markov chain Monte Carlo methods.
    Wijsman EM; Yu D
    Mol Biotechnol; 2004 Nov; 28(3):205-26. PubMed ID: 15542922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.
    Emparan C; Wolters H; Laukötte M; Senninger N
    Transplant Proc; 2005 Jun; 37(5):2069-71. PubMed ID: 15964341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian population modeling of drug dosing adherence.
    Fellows K; Stoneking CJ; Ramanathan M
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):515-25. PubMed ID: 26319548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the reliability of NMR relaxation data analyses: a Markov Chain Monte Carlo approach.
    Abergel D; Volpato A; Coutant EP; Polimeno A
    J Magn Reson; 2014 Sep; 246():94-103. PubMed ID: 25117152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Thurstonian model for quantitative genetic analysis of ranks: a Bayesian approach.
    Gianola D; Simianer H
    Genetics; 2006 Nov; 174(3):1613-24. PubMed ID: 16980397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian Estimation of Correlation between Measures of Blood Pressure Indices, Aerobic Capacity and Resting Heart Rate Variability Using Markov Chain Monte Carlo Simulation and 95% High Density Interval in Female School Teachers.
    Shalfawi SAI
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32947985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facility-Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program.
    Bradley SM; O'Donnell CI; Grunwald GK; Liu CF; Hebert PL; Maddox TM; Jesse RL; Fihn SD; Rumsfeld JS; Ho PM
    Circulation; 2015 Jul; 132(2):101-8. PubMed ID: 25951833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bivariate zero-inflated regression for count data: a Bayesian approach with application to plant counts.
    Majumdar A; Gries C
    Int J Biostat; 2010; 6(1):Article 27. PubMed ID: 21969981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional form and risk adjustment of hospital costs: Bayesian analysis of a Box-Cox random coefficients model.
    Hollenbeak CS
    Stat Med; 2005 Oct; 24(19):3005-18. PubMed ID: 15977298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desirable BUGS in models of infectious diseases.
    Auzenbergs M; Correia-Gomes C; Economou T; Lowe R; O'Reilly KM
    Epidemics; 2019 Dec; 29():100361. PubMed ID: 31668494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.